CompletedNCT02461927
Ketamine With Naltrexone or Alone for Depression and Alcohol Use
About this title
Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
Read the official source — NCT02461927Medication studyAges 21–65United States
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
- Listed locations
- West HavenSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: January 1, 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 65
- Sponsor
- VA Office of Research and Development
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT02461927
- Official title
Show the full official title
Ketamine for The Rapid Treatment of Major Depression and Alcohol Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
West Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Office of Research and Development, a government agency.
Did this study involve medication?
Yes. The study involved medication, including Ketamine + Naltrexone, Ketamine + Placebo and Placebo (psychoactive placebo midazolam) + Placebo.
Who was this study for?
Listed age limits: 21 years to 65 years.
